Earnings summaries and quarterly performance for Avantor.
Executive leadership at Avantor.
Emmanuel Ligner
Detailed
President and Chief Executive Officer
CEO
BG
Benoit Gourdier
Detailed
Executive Vice President, Bioscience Production
BJ
Brent Jones
Detailed
Executive Vice President and Chief Financial Officer
CS
Claudius Sokenu
Detailed
Executive Vice President, Chief Legal and Compliance Officer
JB
James Bramwell
Detailed
Executive Vice President, Sales and Customer Excellence
Board of directors at Avantor.
GL
Gregory Lucier
Detailed
Director
GS
Gregory Summe
Detailed
Director
JC
John Carethers
Detailed
Director
JP
Jonathan Peacock
Detailed
Chairman of the Board
JM
Joseph Massaro
Detailed
Director
JA
Juan Andres
Detailed
Director
LK
Lan Kang
Detailed
Director
LM
Louise Makin
Detailed
Director
MM
Mala Murthy
Detailed
Director
MS
Michael Severino
Detailed
Director
Research analysts who have asked questions during Avantor earnings calls.
Daniel Brennan
TD Cowen
6 questions for AVTR
Also covers: A, ADPT, BDSX +24 more
Luke Sergott
Barclays
6 questions for AVTR
Also covers: A, BRKR, CERT +19 more
Michael Ryskin
Bank of America Merrill Lynch
6 questions for AVTR
Also covers: A, ALGN, BRKR +28 more
Tycho Peterson
Jefferies
6 questions for AVTR
Also covers: A, BIO, BLLN +22 more
Vijay Kumar
Evercore ISI
6 questions for AVTR
Also covers: A, ABT, AZTA +21 more
Patrick Donnelly
Citi
5 questions for AVTR
Also covers: A, BIO, BRKR +21 more
Douglas Schenkel
Wolfe Research, LLC
3 questions for AVTR
Also covers: A, BRKR, DHR +21 more
Doug Schenkel
Wolfe Research LLC
3 questions for AVTR
Also covers: A, BRKR, DHR +15 more
RV
Rachel Vatnsdal Olson
JPMorgan
3 questions for AVTR
Also covers: A, ADPT, AKYA +14 more
TS
Tejas Savant
Morgan Stanley
3 questions for AVTR
Also covers: ADPT, AKYA, CRL +19 more
CN
Conor Noel McNamara
RBC Capital Markets
2 questions for AVTR
Also covers: BIO, HOLX, ILMN +6 more
DL
Dan Leonard
UBS Group AG
2 questions for AVTR
Also covers: A, BIO, DHR +9 more
Brandon Couillard
Wells Fargo & Company
1 question for AVTR
Also covers: A, BIO, BRKR +10 more
DA
Daniel Arias
Stifel, Nicolaus & Company, Incorporated
1 question for AVTR
Also covers: A, CDXS, DHR +15 more
DL
Daniel Leonard
Stifel Financial Corp.
1 question for AVTR
Also covers: A, BIO, CRL +15 more
Jack Meehan
Nephron Research LLC
1 question for AVTR
Also covers: A, BIO, CARS +17 more
MS
Matthew Sykes
Goldman Sachs Group Inc.
1 question for AVTR
Also covers: A, ADPT, CRL +21 more
Rachel Vatnsdal
JPMorgan Chase & Co.
1 question for AVTR
Also covers: A, AKYA, CARS +11 more
Recent press releases and 8-K filings for AVTR.
Avantor Faces Federal Securities Class Action Lawsuit
AVTR
Legal Proceedings
Guidance Update
CEO Change
- Faruqi & Faruqi, LLP has announced a federal securities class action lawsuit against Avantor, Inc. (AVTR) on behalf of investors who purchased securities between March 5, 2024, and October 28, 2025.
- The lawsuit alleges that Avantor and its executives made false and misleading statements regarding the company's competitive positioning and failed to disclose the negative impact of increased competition.
- This follows several announcements of disappointing financial results in 2025, including a 16.5% stock decline on April 25, 2025, after cutting guidance and announcing the CEO would step down, and a further 23% decline on October 29, 2025, after reporting a $712 million net loss and -5% organic revenue growth.
- The deadline for investors to seek the role of lead plaintiff is December 29, 2025.
1 day ago
Avantor Faces Shareholder Investigation Over Securities Law Violations
AVTR
Legal Proceedings
Guidance Update
CEO Change
- Faruqi & Faruqi, LLP is investigating Avantor (NYSE: AVTR) for potential securities law violations, covering investors who purchased securities between March 5, 2024, and October 28, 2025.
- The investigation alleges that Avantor made false and misleading statements regarding its competitive positioning and failed to disclose negative effects from increased competition.
- The company experienced significant stock price declines following disappointing financial results and guidance cuts on April 25, 2025 (down 16.5%), August 1, 2025 (down 15%), and October 29, 2025 (down 23%).
- These events included the stepping down of CEO Michael Stubblefield, reduced guidance, and a $785 million goodwill impairment in Q3 2025, all attributed to increased competitive intensity.
- The deadline for investors to seek the role of lead plaintiff in the federal securities class action is December 29, 2025.
4 days ago
Avantor Faces Securities Fraud Lawsuit
AVTR
Legal Proceedings
Guidance Update
Demand Weakening
- A class action lawsuit has been filed against Avantor, Inc. (AVTR) on behalf of investors who purchased common stock between March 5, 2024 and October 28, 2025, alleging materially false and/or misleading statements by the company.
- Investors have until December 29, 2025, to file a lead plaintiff motion in the class action.
- The lawsuit stems from multiple stock price drops in 2025 following disappointing financial results and guidance cuts, with Avantor's stock falling 16.6% on April 25, 2025, 15.5% on August 1, 2025, and 23.2% on October 29, 2025.
- Key issues cited include increased competitive intensity, missed consensus estimates, reduced guidance, -5% organic revenue growth in Q3 2025, a $712 million net loss (including a $785 million goodwill impairment), and the loss of large accounts.
6 days ago
Avantor Investors Face Lead Plaintiff Deadline in Securities Class Action
AVTR
Legal Proceedings
Demand Weakening
Guidance Update
- Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. (NYSE: AVTR), alleging the company made false or misleading statements regarding its competitive positioning and the impact of increased competition.
- Investors who purchased Avantor securities between March 5, 2024, and October 28, 2025, have until December 29, 2025, to seek the role of lead plaintiff in the federal securities class action.
- The lawsuit highlights several events where Avantor's stock declined significantly due to disappointing financial results and revised guidance, which the company attributed to "increased competitive intensity" and "competitive pressures".
- Specific stock declines occurred on April 25, 2025, (over 16.5%), August 1, 2025, (over 15%), and October 29, 2025, (over 23%), following announcements of weak performance, reduced guidance, and a $785 million goodwill impairment charge.
6 days ago
Avantor Faces Federal Securities Class Action Investigation
AVTR
Legal Proceedings
Guidance Update
CEO Change
- Faruqi & Faruqi, LLP is investigating Avantor (AVTR) for alleged federal securities law violations, claiming the company made false or misleading statements about its competitive positioning and the impact of increased competition.
- The class period for affected investors is from March 5, 2024, to October 28, 2025, with a deadline to seek lead plaintiff status by December 29, 2025.
- The investigation stems from multiple negative announcements in 2025, including disappointing Q1 and Q2 financial results, reduced 2025 guidance, a CEO change, and a Q3 2025 net loss of $712 million driven by a $785 million goodwill impairment charge.
- These events led to significant stock price declines, with drops of over 16.5% on April 25, 2025, over 15% on August 1, 2025, and over 23% on October 29, 2025.
8 days ago
Avantor Faces Federal Securities Class Action Lawsuit
AVTR
Legal Proceedings
Guidance Update
CEO Change
- Faruqi & Faruqi, LLP has filed a federal securities class action against Avantor, Inc. (AVTR), alleging the company made false or misleading statements about its competitive positioning and the impact of increased competition between March 5, 2024, and October 28, 2025.
- The complaint highlights several stock declines, including a $2.57 per share (over 16.5%) drop on April 25, 2025, after disappointing Q1 2025 results, reduced guidance, and the CEO stepping down.
- Further declines occurred on August 1, 2025, by $2.08 per share (over 15%) following weak Q2 2025 results and further reduced guidance , and on October 29, 2025, by $3.50 per share (over 23%) after weak Q3 2025 results, which included a net loss of $712 million and a $785 million goodwill impairment charge.
- Investors who purchased Avantor securities during the class period have until December 29, 2025, to seek the role of lead plaintiff.
Dec 11, 2025, 3:03 PM
Avantor Faces Securities Class Action Lawsuit
AVTR
Legal Proceedings
Guidance Update
Demand Weakening
- Faruqi & Faruqi, LLP is investigating Avantor (AVTR) due to a federal securities class action filed against the company, alleging false and/or misleading statements regarding its competitive positioning and the effects of increased competition between March 5, 2024, and October 28, 2025.
- The lawsuit highlights Avantor's disappointing Q1 2025 results on April 25, 2025, which led to a 16.5% stock decline and the stepping down of CEO Michael Stubblefield, and further reduced 2025 guidance on August 1, 2025, causing a 15% stock drop.
- On October 29, 2025, Avantor reported weak Q3 2025 results, including a $712 million net loss primarily due to a $785 million goodwill impairment charge attributed to competitive pressures, resulting in a 23% decline in stock price.
- Investors who purchased Avantor securities during the class period have until December 29, 2025, to seek the role of lead plaintiff in the class action.
Dec 5, 2025, 4:30 PM
Avantor Faces Securities Class Action Lawsuit
AVTR
Legal Proceedings
Guidance Update
Demand Weakening
- A class action lawsuit has been filed against Avantor, Inc. (NYSE: AVTR) on behalf of investors who purchased common stock between March 5, 2024, and October 28, 2025.
- The lawsuit alleges that Avantor made false and misleading statements and failed to disclose that its competitive position in key product lines was weaker than represented, and that it was experiencing negative impacts from increased competition affecting volumes, sales, and growth.
- Investors have until December 29, 2025, to seek appointment as lead plaintiff.
- The complaint highlights significant stock price declines following disclosures of weaker-than-expected sales and reduced outlooks on April 25, 2025, disappointing second-quarter results and further reduced guidance on August 1, 2025, and weak third-quarter 2025 financial results on October 29, 2025.
Dec 1, 2025, 10:41 PM
Avantor Investigated for Securities Law Violations
AVTR
Legal Proceedings
Profit Warning
Demand Weakening
- Faruqi & Faruqi, LLP is investigating Avantor, Inc. (NYSE: AVTR) for alleged federal securities law violations during the period of March 5, 2024, to October 28, 2025.
- The complaint alleges Avantor made false or misleading statements about its competitive positioning and failed to disclose the negative impact of increased competition.
- Key events cited include disappointing Q1 2025 financial results and a 16.5% stock decline on April 25, 2025, followed by further reduced 2025 guidance and a 15% stock drop on August 1, 2025.
- On October 29, 2025, Avantor reported weak Q3 2025 results, including a $712 million net loss primarily due to a $785 million non-cash goodwill impairment charge, which led to a 23% stock decline.
- Investors have until December 29, 2025, to seek the role of lead plaintiff in the federal securities class action.
Nov 29, 2025, 1:44 PM
Avantor Faces Securities Fraud Lawsuit
AVTR
Legal Proceedings
Guidance Update
Demand Weakening
- A class action lawsuit has been filed against Avantor, Inc. (AVTR) on behalf of investors who purchased common stock between March 5, 2024, and October 28, 2025.
- The lawsuit alleges that Avantor made materially false and/or misleading statements and failed to disclose adverse facts, specifically regarding its competitive positioning and the negative impact of increased competition.
- The company's stock price experienced significant drops following financial announcements, including a 16.6% fall on April 25, 2025, a 15.5% fall on August 1, 2025, and a 23.2% fall on October 29, 2025.
- These declines followed Avantor missing consensus estimates and cutting guidance in Q1 and Q2 2025, and reporting a -5% organic revenue growth and a net loss of $712 million in Q3 2025, primarily due to a $785 million goodwill impairment charge.
- Investors have until December 29, 2025, to file a lead plaintiff motion in the class action.
Nov 13, 2025, 6:07 PM
Quarterly earnings call transcripts for Avantor.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more